» Articles » PMID: 29561768

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2018 Mar 22
PMID 29561768
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV) oncogenic protein that has no intrinsic enzymatic activity or sequence homology to cellular or viral proteins. The oncogenic potential of LMP1 has been ascribed to pleiotropic signaling properties initiated through protein-protein interactions in cytosolic membrane compartments, but the effects of LMP1 extend to nuclear and extracellular processes. Although LMP1 is one of the latent genes required for EBV-immortalization of B cells, the biology of LMP1 in the pathogenesis of the epithelial cancer nasopharyngeal carcinoma (NPC) is more complex. NPC is prevalent in specific regions of the world with high incidence in southeast China. The epidemiology and time interval from seroconversion to NPC onset in adults would suggest the involvement of multiple risk factors that complement the establishment of a latent and persistent EBV infection. The contribution of LMP1 to EBV pathogenesis in polarized epithelia has only recently begun to be elucidated. Furthermore, the LMP1 gene has emerged as one of the most divergent sequences in the EBV genome. This review will discuss the significance of recent advances in NPC research from elucidating LMP1 function in epithelial cells and lessons that could be learned from mining LMP1 sequence diversity.

Citing Articles

High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma.

Warner B, Shair K J Clin Invest. 2025; 135(4).

PMID: 39959976 PMC: 11827836. DOI: 10.1172/JCI189207.


Inhibition of the Integrated stress response by Epstein-Barr virus oncoprotein LMP1 attenuates epithelial cell differentiation and lytic viral reactivation.

Singh D, Zhang Y, White S, Nelson S, Fogarty S, Pawelski A PLoS Pathog. 2025; 21(2):e1012934.

PMID: 39951426 PMC: 11828382. DOI: 10.1371/journal.ppat.1012934.


Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein.

Khenchouche A, Salem-Bekhit M, Mansour A, Alomary M, Wang X, Alzahrani H Microorganisms. 2023; 11(7).

PMID: 37512884 PMC: 10383785. DOI: 10.3390/microorganisms11071712.


Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-κB positive feedback loop.

Xin S, Liu L, Li Y, Yang J, Zuo L, Cao P Virol Sin. 2022; 37(6):913-921.

PMID: 36075565 PMC: 9797372. DOI: 10.1016/j.virs.2022.09.001.


Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target.

Kobayashi E, Kondo S, Dochi H, Moriyama-Kita M, Hirai N, Komori T Cancers (Basel). 2022; 14(12).

PMID: 35740492 PMC: 9220992. DOI: 10.3390/cancers14122826.


References
1.
Crawford D, Epstein M, Bornkamm G, ACHONG B, Finerty S, Thompson J . Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int J Cancer. 1979; 24(3):294-302. DOI: 10.1002/ijc.2910240305. View

2.
Imai S, Nishikawa J, Takada K . Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol. 1998; 72(5):4371-8. PMC: 109667. DOI: 10.1128/JVI.72.5.4371-4378.1998. View

3.
Yip Y, Pang P, Deng W, Tsang C, Zeng M, Hau P . Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study. PLoS One. 2013; 8(10):e78395. PMC: 3805559. DOI: 10.1371/journal.pone.0078395. View

4.
Aga M, Bentz G, Raffa S, Torrisi M, Kondo S, Wakisaka N . Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene. 2014; 33(37):4613-22. PMC: 4162459. DOI: 10.1038/onc.2014.66. View

5.
Renzette N, Somasundaran M, Brewster F, Coderre J, Weiss E, McManus M . Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids. J Virol. 2014; 88(7):3744-55. PMC: 3993555. DOI: 10.1128/JVI.03378-13. View